uniQure N.V. (QURE) has 7 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 3 sales totalling $13.6M. Most recent filing: July 7, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| July 7, 2026 filed July 2, 2026 | Kapusta Matthew C CEO, Managing Director | $543,271 | 63,246 | — | Yes | |
|
|
||||||
| July 2, 2026 filed June 30, 2026 | Kaye Jack Director | $199,851 | 63,501 | — | Yes | |
|
|
||||||
| June 30, 2026 filed June 26, 2026 | Abi-Saab Walid Chief Medical Officer | −$67,197 | 1,434 | −1% | No | |
|
|
||||||
| June 26, 2026 filed June 24, 2026 | Kapusta Matthew C CEO, Managing Director | −$128,442 | 101,100 | −5% | Yes | |
|
|
||||||
| June 22, 2026 filed June 17, 2026 | Kapusta Matthew C CEO, Managing Director | −$6,314,266 | 340,574 | −64% | Yes | |
|
|
||||||
Showing the 5 most recent of 7 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free